test

Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer

Conditions

Esophagus

What is the purpose of this trial?

To induce a pCR rate of 20% in PET scan non-responders treated with either induction FOLFOX or carboplatin/paclitaxel, who then cross over to the other regimen during radiotherapy.


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
CALGB
Dates:
10/16/2012
Last Updated:
Study HIC#:
1204010075